N-Acetylcysteine Alleviates the Progression of Chronic Kidney Disease: A Three-Year Cohort Study

N-Acetylcysteine Alleviates the Progression of Chronic Kidney Disease: A Three-Year Cohort Study

<i>Background and Objectives</i>: The prevalence of chronic kidney disease (CKD) is approximately 10% of the population in many countries. CKD progresses to end-stage renal disease (ESRD), resulting in adverse outcomes, prolonged hospitalization, and increased healthcare costs. Therefore...

Full description

Bibliographic Details
Main Authors: Ai-Hua Chiu, Chih-Jen Wang, Ya-Ling Lin, Chia-Liang Wang, Tsay-I Chiang
Format: Article
Language:English
Published: MDPI AG 2023-11-01
Series:Medicina
Subjects:
N-acetylcysteine
chronic kidney disease
end-stage renal disease
Online Access:https://www.mdpi.com/1648-9144/59/11/1983

Similar Items

Similar Items